Get startedLog in
    Picture of Entropy Neurodynamics logo

    ENP — Entropy Neurodynamics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Exopharm Updates on Results From Plexoval II Phase I Safety Study With Plexaris

    Picture of Entropy Neurodynamics logoEntropy Neurodynamics
    06/04/2021 02:20
    April 6 (Reuters) - Exopharm Ltd  EX1.AX :
    * EXOPHARM LTD - RESULTS FROM PLEXOVAL II PHASE I SAFETY
STUDY
WITH PLEXARIS FOUND THERE WERE NO UNTOWARD OR UNEXPECTED SAFETY
EVENTS REPORTED

Source text for Eikon:  ID:nASX3Mkjv6 
Further company coverage:  EX1.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Entropy Neurodynamics

    See all news